What is the glutamine dosage?
| Label | Form | Strength | Supply |
|---|---|---|---|
| Endari (US label) | L-glutamine oral powder | 5 g per packet | Carton of 60 packets1 |
| Camber generic L-glutamine (US label) | L-glutamine oral powder | 5 g per packet | Carton of 60 packets3 |
Strengths and forms
The table is set at the top of the page
Searches of DailyMed found no tablet or capsule strengths; supplement product pages were not checked.
Mixing and taking the powder
The Endari label mixes each dose in 8 oz (240 mL) of cold or room-temperature beverage, or in 4 to 6 oz of food.1 It names water, milk or apple juice as beverages and applesauce or yogurt as foods, and says complete dissolution is not required.1 The ClinicalTrials.gov entry of the Niihara phase 3 trial (NCT01179217) says the powder can be mixed with water or most non-heated beverages other than alcohol, and that mixing it with soda or highly acidic juices, such as grapefruit juice or lemonade, is not recommended.4
Label dose by body weight and schedule
The Endari label gives 5 to 15 g by mouth twice daily, by body weight, with no more than 6 packets per day.1 It says not to double the dose to make up for a missed dose.1
Doses used in trials
The label's trial summary pools 2 placebo-controlled trials (a phase 3 study, n=230, and a phase 2 study, n=70), in which patients aged 5 to 58 with sickle cell anemia or sickle β0-thalassemia were randomized to Endari (n=187) or placebo (n=111) orally twice daily for 48 weeks followed by 3 weeks of tapering.1 In a 2024 open-label dose-ascending study by Sadaf and colleagues, in 8 children and adults with sickle cell disease and 4 healthy adults, the authors report that doses higher than 0.3 g/kg do not yield substantially higher blood concentrations and that food intake did not alter glutamine clearance.5
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Niihara 2018, sickle cell phase 3, against placebo | 0.3 g per kilogram of body weight per dose, by mouth, twice daily | 230 patients aged 5 to 58 with sickle cell anemia or sickle β0-thalassemia: 152 on glutamine, 78 on placebo2 | 48 weeks |
| Sadaf 2024, open-label dose-ascending study | 0.1 and 0.3 g/kg twice daily, then 0.6 g/kg once daily, by mouth | 8 children and adults with sickle cell disease and 4 healthy adults5 | Three ascending doses over 3 weeks |
| Heyland 2013, critically ill adults, 2-by-2 factorial against antioxidants, both or placebo | Intravenous and enteral, started within 24 hours after ICU admission; the trial summary gives no dose | 1223 adults with multiorgan failure on mechanical ventilation, in 40 ICUs6 | Not stated |
| Heyland 2022, RE-ENERGIZE burns, against placebo | 0.5 g per kilogram of body weight per day, enteral, every 4 hours by tube or three or four times a day by mouth | 1200 patients with deep second- or third-degree burns analysed: 596 on glutamine, 604 on placebo7 | Until 7 days after the last skin grafting procedure, discharge from the acute care unit, or 3 months after admission, whichever came first |
| Legault 2015, eccentric exercise, placebo-controlled crossover | 0.3 g·kg-1·day-1 L-glutamine, once per day, against a maltodextrin placebo | 16 healthy participants aged 22 ± 4 years8 | 72 hr |
In the Heyland 2013 trial, 28-day mortality was 32.4% among patients who received glutamine against 27.2% among those who did not, which the authors report as a trend toward increased mortality.6
Glutamine dose for gut health
The Endari label states its indication as reducing acute complications of sickle cell disease in patients 5 years and older, and names no gut-health use.1 Searches of DailyMed, ClinicalTrials.gov and PubMed found no label for gut health or leaky gut. A 2024 meta-analysis by Abbasi and colleagues of 10 placebo-controlled trials with 352 participants reports that, overall, glutamine supplementation did not significantly affect intestinal permeability, and says further investigations with varying dosages and patient populations are warranted.9 The searches also found no label for glutamine as a general supplement; the Endari and generic labels are for sickle cell disease only.
Storage before and after mixing
The Endari label says to store packets at 20 to 25 °C, away from direct sunlight.1 Its patient leaflet says to take the dose right away after mixing and not to store the mixture, and the Camber generic label also says not to store the mixed powder for later use.13 Searches of the labels found no stability time for a mixture.
Frequently asked questions
How many mL or syringe units is a glutamine dose?
The labels supply glutamine as dry 5 g packets, with no concentration per mL, so only gram doses are stated.1 A DailyMed search found no liquid or injectable glutamine with a mg/mL strength.
References
- DailyMed. These highlights do not include all the information needed to use ENDARI™ safely and effectively. See full prescribing information for ENDARI. ENDARI (L-glutamine oral powder ) Initial U.S. Approval: 2017. 2025. dailymed.nlm.nih.gov
- PubMed. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. 2018. pubmed.ncbi.nlm.nih.gov
- DailyMed. These highlights do not include all the information needed to use L-GLUTAMINE ORAL POWDER safely and effectively. See full prescribing information for L-GLUTAMINE ORAL POWDER. L-GLUTAMINE oral powder Initial U.S. Approval: 2017. 2026. dailymed.nlm.nih.gov
- ClinicalTrials.gov. NCT01179217: A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia. 2017. clinicaltrials.gov
- PubMed Central. A Population Pharmacokinetic Analysis of l -Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects. 2024. pmc.ncbi.nlm.nih.gov
- PubMed. A randomized trial of glutamine and antioxidants in critically ill patients. 2013. pubmed.ncbi.nlm.nih.gov
- PubMed. A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries. 2022. pubmed.ncbi.nlm.nih.gov
- PubMed. The Influence of Oral L-Glutamine Supplementation on Muscle Strength Recovery and Soreness Following Unilateral Knee Extension Eccentric Exercise. 2015. pubmed.ncbi.nlm.nih.gov
- PubMed. A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults. 2024. pubmed.ncbi.nlm.nih.gov